Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical Grade Cannabis in Children with Autism Spectrum Disorder
NCT05413187Phase 2Withdrawn
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of medical cannabis in Autism Spectrum Disorder (ASD). Planned start Sep 2020; status: withdrawn.
02
Drugs
medical cannabis
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05413187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05413187.